Subcutaneous patient-controlled analgesia (SCPCA) in home-based palliative care is a potentially valuable option for providing effective pain relief to some patients, particularly when conventional analgesic approaches prove ineffective or are refused. Our case report illustrates the use of SPCA for the management of breakthrough pain in a patient receiving palliative care at home with no improvement after multiple previous treatments. SCPCA was found to be safe and successful. Future research is essential to explore its precise role, appropriate indications, prescription guidelines, and safety considerations across various palliative care contexts.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/15360288.2024.2320404 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!